Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at PLN 107.7B, ahead of Eli Lilly (PLN 82.9B) and Merck & Co (PLN 73.3B). Figures as of 19 Nov 2026, 08:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonPLN 107.7B
- Median
- PLN 1.1B
- Combined market value
- PLN 36.53T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | PLN 515.6M | PLN 16.1B | PLN 68.49 | 2.85% down | 51% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | PLN 499.9M | PLN 24B | PLN 1,199.92 | 1.67% up | 43% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | PLN 400.3M | PLN 29.8B | PLN 272.31 | 3.25% down | 8% down | ||
| 104 | HaemoneticsHAE · Health Care | PLN 390.9M | PLN 22.5B | PLN 493.53 | 1.60% up | 61% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | PLN 289.5M | PLN 30.6B | PLN 87.89 | 3.60% up | 83% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 237M | PLN 30B | PLN 381.81 | 0.06% down | 126% up | ||
| 107 | RepligenRGEN · Health Care | PLN 196.4M | PLN 44.3B | PLN 693.61 | 6.47% up | 5% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | PLN 38.8M | PLN 21B | PLN 55.31 | 2.82% down | 129% up | ||
| 109 | BillionToOneBLLN · Health Care | PLN 29.9M | PLN 17.6B | PLN 367.72 | 6.11% down | 0% up | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -PLN 6.6M | PLN 24.5B | PLN 173.17 | 0.28% up | 10% up | ||
| 111 | BrukerBRKR · Health Care | -PLN 34.5M | PLN 38.8B | PLN 254.11 | 3.10% up | 41% up | ||
| 112 | RadNetRDNT · Health Care | -PLN 74.9M | PLN 22.7B | PLN 288.50 | 4.14% down | 7% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -PLN 93.8M | PLN 24.3B | PLN 371.53 | 0.59% up | 31% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -PLN 102.6M | PLN 19.4B | PLN 201.81 | 1.68% down | 44% up | ||
| 115 | 10x GenomicsTXG · Health Care | -PLN 174.9M | PLN 30.2B | PLN 229.25 | 1.37% up | 260% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -PLN 239M | PLN 18.5B | PLN 114.32 | 0.11% down | 88% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -PLN 273.5M | PLN 22.5B | PLN 78.33 | 2.21% down | 17% down | ||
| 118 | VeradermicsMANE · Health Care | -PLN 281.2M | PLN 21.2B | PLN 501.56 | 0.62% down | 233% up | ||
| 119 | Belite BioBLTE · Health Care | -PLN 311.8M | PLN 25.5B | PLN 627.57 | 0.94% down | 31% up | ||
| 120 | Twist BioscienceTWST · Health Care | -PLN 312M | PLN 31.9B | PLN 467.38 | 3.88% up | 340% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -PLN 423.5M | PLN 26.1B | PLN 384.59 | 0.60% down | 241% up | ||
| 122 | HeartflowHTFL · Health Care | -PLN 469.1M | PLN 16.2B | PLN 184.34 | 2.51% down | 73% up | ||
| 123 | ErascaERAS · Health Care | -PLN 500.3M | PLN 19.4B | PLN 55.27 | 0.94% down | 403% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -PLN 522.8M | PLN 33.3B | PLN 510.80 | 2.00% up | 46% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -PLN 579.8M | PLN 64.1B | PLN 1,338.66 | 0.33% up | 105% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -PLN 623.4M | PLN 38.7B | PLN 407.56 | 8.15% up | 286% up | ||
| 127 | CG OncologyCGON · Health Care | -PLN 646.7M | PLN 28.7B | PLN 321.36 | 1.34% up | 85% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -PLN 652.1M | PLN 19B | PLN 337.35 | 3.45% down | 113% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -PLN 674M | PLN 18.2B | PLN 166.18 | 1.59% down | 88% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -PLN 735.8M | PLN 28.3B | PLN 538.28 | 1.43% down | 7% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -PLN 738.3M | PLN 16B | PLN 116.97 | 0.88% down | 169% up | ||
| 132 | GlaukosGKOS · Health Care | -PLN 754M | PLN 55.4B | PLN 936.28 | 4.18% down | 152% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -PLN 789.5M | PLN 33.2B | PLN 478.18 | 2.08% up | 13% up | ||
| 134 | NateraNTRA · Health Care | -PLN 836.2M | PLN 168.6B | PLN 1,162.92 | 0.71% up | 32% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -PLN 923.8M | PLN 25.7B | PLN 392.90 | 1.04% up | 396% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -PLN 931.9M | PLN 53.6B | PLN 107.25 | 3.29% up | 20% up | ||
| 137 | LivaNovaLIVN · Health Care | -PLN 974M | PLN 20.9B | PLN 379.77 | 2.85% up | 71% up | ||
| 138 | Ascendis PharmaASND · Health Care | -PLN 1B | PLN 71.2B | PLN 1,085.91 | 0.32% down | 28% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -PLN 1.2B | PLN 37.1B | PLN 1,599.08 | 5.67% down | 24% down | ||
| 140 | Legend BiotechLEGN · Health Care | -PLN 1.2B | PLN 12.7B | PLN 65.28 | 0.87% up | 42% down | ||
| 141 | Roivant SciencesROIV · Health Care | -PLN 1.2B | PLN 112.7B | PLN 155.58 | 0.05% up | 90% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -PLN 1.2B | PLN 34.3B | PLN 1,225.95 | 0.04% up | 61% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -PLN 1.3B | PLN 41.5B | PLN 486.58 | 0.32% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -PLN 1.3B | PLN 19.4B | PLN 111.71 | 0.14% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -PLN 1.3B | PLN 19.2B | PLN 68.25 | 4.44% down | 4% down | ||
| 146 | ImmunityBioIBRX · Health Care | -PLN 1.4B | PLN 28.6B | PLN 26.91 | 7.03% up | 193% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -PLN 1.4B | PLN 63.9B | PLN 995.29 | 2.93% up | 37% up | ||
| 148 | Bausch + LombBLCO · Health Care | -PLN 1.4B | PLN 30.1B | PLN 84.16 | 0.58% up | 42% up | ||
| 149 | ABIVAXABVX · Health Care | -PLN 1.5B | PLN 29.5B | PLN 336.74 | 2.11% up | 27% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -PLN 1.5B | PLN 23.5B | PLN 192.82 | 6.48% up | 14% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -PLN 1.5B | PLN 18.3B | PLN 110.03 | 1.59% up | 64% down | ||
| 152 | GRAILGRAL · Health Care | -PLN 1.6B | PLN 18.4B | PLN 410.13 | 3.57% down | 20% up | ||
| 153 | Guardant HealthGH · Health Care | -PLN 1.7B | PLN 78.9B | PLN 583.03 | 1.30% up | 44% up | ||
| 154 | Oscar HealthOSCR · Health Care | -PLN 1.8B | PLN 34.4B | PLN 110.75 | 7.61% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -PLN 2B | PLN 27.6B | PLN 133.24 | 0.12% down | 43% up | ||
| 156 | AvantorAVTR · Health Care | -PLN 2.1B | PLN 41.8B | PLN 61.74 | 1.25% up | 38% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -PLN 2.3B | PLN 15.7B | PLN 161.44 | 0.10% up | 21% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -PLN 2.9B | PLN 61B | PLN 313.37 | 1.58% up | 17% up | ||
| 159 | VaxcytePCVX · Health Care | -PLN 3.1B | PLN 37.2B | PLN 235.07 | 1.48% down | 22% up | ||
| 160 | CytokineticsCYTK · Health Care | -PLN 3.2B | PLN 28.7B | PLN 206.15 | 0.64% down | 20% down | ||
| 161 | TeleflexTFX · Health Care | -PLN 3.6B | PLN 26.4B | PLN 666.22 | 3.95% up | 51% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -PLN 3.8B | PLN 273B | PLN 85.44 | 1.71% down | 54% up | ||
| 163 | Baxter InternationalBAX · Health Care | -PLN 3.8B | PLN 54.4B | PLN 105.08 | 1.55% up | 46% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -PLN 4.3B | PLN 33.7B | PLN 42.18 | 1.59% down | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -PLN 4.5B | PLN 138.9B | PLN 642.00 | 1.76% down | 131% up | ||
| 166 | BioNTechBNTX · Health Care | -PLN 5.1B | PLN 82.9B | PLN 334.45 | 1.89% down | 16% down | ||
| 167 | InsmedINSM · Health Care | -PLN 5.1B | PLN 105.6B | PLN 481.24 | 1.69% down | 40% down | ||
| 168 | ModernaMRNA · Health Care | -PLN 11.3B | PLN 319.9B | PLN 790.50 | 4.84% down | 755% up | ||
| 169 | ViatrisVTRS · Health Care | -PLN 14.1B | PLN 93.4B | PLN 81.46 | 0.83% down | 96% up | ||
| 170 | CenteneCNC · Health Care | -PLN 26.8B | PLN 134.1B | PLN 270.95 | 7.03% down | 102% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0170 PLN).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (PLN 107.7B), Eli Lilly (PLN 82.9B) and Merck & Co (PLN 73.3B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 08:24 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of PLN 36.53T as of 19 Nov 2026, 08:24 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.